New Analysis in Treating Non-Hodgkin Lymphoma and Predicting the Possibility of Early Illness Development: ASH Annual Assembly 2022

The 2022 American Society of Hematology (ASH) Annual Assembly and Exposition was once held from December 10 to 13 in New Orleans, Louisiana.

On this podcast, Christopher Plant life, MD, FASCO, discusses analysis introduced on the assembly, together with new remedies for non-Hodgkin lymphoma and new fashions for predicting which sufferers is also in peril for early illness development.

    • The FLIPI24 fashion used age, hemoglobin ranges, white blood mobile rely, lactate dehydrogenase ranges, and beta-2-microglobulin ranges to expect which sufferers with follicular lymphoma is also in peril for early illness development. [5:00]

    • The CCP-32 predictor used genomics to expect which sufferers with diffuse huge B-cell lymphoma is also in peril for early illness development. [6:11]

  • An replace on a kind of immunotherapy mentioned on the assembly known as bispecific antibodies, which carry T cells into the tumor to assault the lymphoma cells. [7:11]

Dr. Plant life is the Chair of the Division of Lymphoma/Myeloma at The College of Texas MD Anderson Most cancers Heart and was once appointed Department Head advert meantime of Most cancers Drugs in August 2020. Dr. Plant life may be the 2023 Most cancers.Internet Affiliate Editor for Lymphoma.

Disclosure knowledge for Dr. Plant life will also be present in his biography related to above.

Was once this podcast helpful? Please subscribe, charge, and overview Most cancers.Internet Podcasts anyplace you concentrate to podcasts. This prerecorded podcast will also be listened to on-line or downloaded in your laptop. A transcript may be to be had. For more info, talk over with the Most cancers.Internet podcast web page.

Most cancers.Internet podcasts are edited for duration and content material.

Share Us

Inquiry Now